Bicycle Therapeutics to Participate in Upcoming Investor Conferences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/25/2026
- Wall Street ends higher as tech rebounds before Nvidia results
- Oil settles down more than 3%; investors shrug off US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Grand Canyon Education places CFO on leave amid stock trade probe
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- Funds sell $44bn in semiconductors on AI concerns
Cantor Fitzgerald Reiterates Overweight Rating on Bicycle Therapeutics (BCYC)
June 3, 2024 10:44 AM EDTCantor Fitzgerald analyst Li Watsek reiterated an Overweight rating on Bicycle Therapeutics (NASDAQ: BCYC).
The analyst comments "We hosted an investor dinner with members of the Bicycle team over the weekend at ASCO (CFO Alethia Young, SVP, head of Commercial Jennifer Perry, and... More
